Editorial: Kidney cancer - A unique opportunity for the development of disease specific therapy

Journal of Urology

Volumn 168, Issue 6, 2002, Pages 2411-2412

  Linehan, W Marston ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; INTERFERON; INTERLEUKIN 2; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR;

BIRT HOGG DUBE SYNDROME; CANCER GENETICS; CANCER THERAPY; CLEAR CELL CARCINOMA; CLINICAL TRIAL; CRYOTHERAPY; DRUG EFFECT; EDITORIAL; FAMILIAL CANCER; HUMAN; KIDNEY CANCER; LEIOMYOMA; NEPHRECTOMY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY; STEM CELL TRANSPLANTATION; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0036896474     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64156-0     Document Type: Editorial

References (18)

1. Linehan, W. M., Zbar, B. and Klausner, R. D.: Renal carcinoma. In: The Genetic Basis of Human Cancer, 2nd Ed. Edited by B. Vogelstein and K. W. Kinzler. New Yorj: McGraw-Hill, 2002
2. Chow, W. H., Devesa, S. S., Warren, J. L. and Fraumeni, J. F., Jr.: Rising incidence of renal cell cancer in the United States. JAMA, 281: 1628, 1999
3. Yang, J. C., Topalian, S. L., Parkinson, D., Schwartzentruber, D. J., Weber, J. S., Ettinghausen, S. E. et al: Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: An interim report. J Clin Oncol, 12: 1572, 1994
4. Childs, R., Chernoff, A., Contentin, N., Bahceci, E., Schrump, D., Leitman, S. et al: Regression of metastatic renal cell carcinoma after nonmyeloablative allogeneic peripheral blood stem cell transplantation. N Engl J Med, 343: 750, 2000
5. Latif, F., Tory, K., Gnarra, J. R., Yao, M., Duh, F.-M., Orcutt, M. L. et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 260: 1317, 1993
6. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H. et al: Mutation of the VHL tumour suppressor gene in renal carcinoma. Nat Genet, 7: 85, 1994
7. Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T. Y., Huang, L. E. et al: Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol, 2: 423, 2000
8. Seagroves, T. and Johnson, R. S.: Two HIFs may be better than one. Cancer Cell, 1: 211, 2002
9. Tyers, M. and Rottapel, R.: VHL: A very hip ligase. Proc Natl Acad Sci USA, 96: 12230, 1999
10. Wiesener, M. S., Munchenhagen, P. M., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A. et al: Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxiainducible factor-1 alpha in clear cell renal carcinomas. Cancer Res, 61: 5215, 2001
11. Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P. et al: Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nat Genet, 16: 68, 1997
12. Schmidt, L., Junker, K., Weirich, G., Glenn, G., Choyke, P., Lubensky, I. A. et al: Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res, 58: 1719, 1998
13. Zbar, B., Alvord, G., Glenn, G., Turner, M., Pavlovich, C. P., Schmidt, L. S. et al: Risk of renal and colon neoplasms and spontaneous pneumothorax in the Birt Hogg Dube syndrome. Cancer Epidemiol Biomarkers Prev, 11: 393, 2002
14. Nickerson, M. L., Warren, M. B., Toro, J. R., Matrosova, V., Glenn, G., Turner, M. L. et al: Mutations in a novel gene cause the Birt-Hogg-Dubé syndrome, a genodermatosis with associated pneumothorax/lung cysts and kidney neoplasia. Cancer Cell, 2: 157, 2002
15. Launonen, V., Vierimaa, O., Kiuru, M., Isola, J., Roth, S., Pukkala, E. et al: Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA, 98: 3387, 2001
16. The multiple leiomyoma consortium germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet, 30: 1, 2002
17. Walther, M. M., Choyke, P. L., Glenn, G. M., Lyne, J. C., Rayford, W., Venzon, D. et al: Renal cancer in families with hereditary renal cancer: Prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol, 161: 1475, 1999
18. Herring, J. C., Enquist, E. G., Chernoff, A. C., Linehan, W. M., Choyke, P. L. and Walther, M. M.: Parenchymal sparing surgery in patients with hereditary renal cell carcinoma - 10-Year experience. J Urol, 165: 777, 2001